T-CAG LifeSciences

News:

From eye exams to blood tests and surgery: how doctors use light to diagnose disease | Dialysis firm DaVita misses third-quarter profit estimates on higher costs | Manipal Group's diagnostic arm acquires Mumbai-based iGenetic | China unveils first diagnosis guidelines to battle escalating obesity crisis | ‘RT-PCR labs can be adapted for future disease diagnosis’ | HaystackAnalytics expands infexn Test for infectious diseases | City Imaging & Clinical Labs to expand its services across North India | Spotting Mpox: A Guide to Symptoms and Knowing When to Seek Testing | Understanding KaryoSeq sequencing and its benefits | Agilus Diagnostics launches Pharmacogenomics testing service | Suraksha Diagnostic gets Sebi's go ahead to float IPO | A Pathologist’s Dilemma :The Heart’s Hidden Chamber | ADHD prescribing has changed over the years - a new guide aims to bring doctors up to speed | Study finds how new imaging method accurately detects kidney cancer | Redcliffe Labs expands footprint in South India with acquisition of Celara Diagnostics | Agilus Diagnostics appoints Anil Kapoor as brand ambassador | Krsnaa Diagnostics, Medikabazaar, United Imaging collaborate to establish 30+ imaging centres across tier II-III cities in India | Dr Lal PathLabs sets sights on big buys to expand in south | Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare | Metropolis Healthcare launches ‘Healthy Heart Meter’ campaign in honour of World Heart Day | Teleflex beats quarterly profit estimates on robust medical devices demand | Waters Corp raises annual profit forecast on higher demand for lab equipment | Baxter restarts IV solutions manufacturing line at hurricane-hit facility | GE HealthCare beats Q3 profit estimates on U.S. demand for medical devices | Medical implant maker Exactech files for bankruptcy after recall litigation | Stryker raises annual profit forecast on robust demand for medical, surgical devices | PM Modi inaugurates medical devices plant in Vapi | Swiss hearing aid maker Sonova resumes supplying Costco, source says | NCIL developing indigenous dialysis machine in collaboration with NIT Silchar | Philips cuts sales outlook as China demand wanes | Nurturing a Global Vision: India's Medical Device Industry as a Manufacturing Hub | Import of refurbished, pre-owned medical devices, major setback for India’s MedTech sector: Industry leaders | NovoCure’s wearable device receives FDA approval for metastatic cancer treatment | Baxter expects to restart IV fluids line at hurricane-hit plant within next week | ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices | Edwards forecast fourth-quarter sales below expectations on soft demand for heart devices | Pharma bodies flag risks of refurbished medical gear imports | Dozee unveils Shravan, AI-powered remote parent monitoring service | Imaginarium paves the path for India’s first hand transplant recovery with 3D Printing solution | Medical gear maker Getinge misses forecast for Q3 core profit

T-CAG LifeSciences

News:

From eye exams to blood tests and surgery: how doctors use light to diagnose disease | Dialysis firm DaVita misses third-quarter profit estimates on higher costs | Manipal Group's diagnostic arm acquires Mumbai-based iGenetic | China unveils first diagnosis guidelines to battle escalating obesity crisis | ‘RT-PCR labs can be adapted for future disease diagnosis’ | HaystackAnalytics expands infexn Test for infectious diseases | City Imaging & Clinical Labs to expand its services across North India | Spotting Mpox: A Guide to Symptoms and Knowing When to Seek Testing | Understanding KaryoSeq sequencing and its benefits | Agilus Diagnostics launches Pharmacogenomics testing service | Suraksha Diagnostic gets Sebi's go ahead to float IPO | A Pathologist’s Dilemma :The Heart’s Hidden Chamber | ADHD prescribing has changed over the years - a new guide aims to bring doctors up to speed | Study finds how new imaging method accurately detects kidney cancer | Redcliffe Labs expands footprint in South India with acquisition of Celara Diagnostics | Agilus Diagnostics appoints Anil Kapoor as brand ambassador | Krsnaa Diagnostics, Medikabazaar, United Imaging collaborate to establish 30+ imaging centres across tier II-III cities in India | Dr Lal PathLabs sets sights on big buys to expand in south | Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare | Metropolis Healthcare launches ‘Healthy Heart Meter’ campaign in honour of World Heart Day | Teleflex beats quarterly profit estimates on robust medical devices demand | Waters Corp raises annual profit forecast on higher demand for lab equipment | Baxter restarts IV solutions manufacturing line at hurricane-hit facility | GE HealthCare beats Q3 profit estimates on U.S. demand for medical devices | Medical implant maker Exactech files for bankruptcy after recall litigation | Stryker raises annual profit forecast on robust demand for medical, surgical devices | PM Modi inaugurates medical devices plant in Vapi | Swiss hearing aid maker Sonova resumes supplying Costco, source says | NCIL developing indigenous dialysis machine in collaboration with NIT Silchar | Philips cuts sales outlook as China demand wanes | Nurturing a Global Vision: India's Medical Device Industry as a Manufacturing Hub | Import of refurbished, pre-owned medical devices, major setback for India’s MedTech sector: Industry leaders | NovoCure’s wearable device receives FDA approval for metastatic cancer treatment | Baxter expects to restart IV fluids line at hurricane-hit plant within next week | ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices | Edwards forecast fourth-quarter sales below expectations on soft demand for heart devices | Pharma bodies flag risks of refurbished medical gear imports | Dozee unveils Shravan, AI-powered remote parent monitoring service | Imaginarium paves the path for India’s first hand transplant recovery with 3D Printing solution | Medical gear maker Getinge misses forecast for Q3 core profit

ABOUT US

Who we are

Taking Care of Your Tomorrow

Background

We are fascinated by the revolution of genomics with the addition of new and improved DNA sequencing technologies and its capability to bring change in our day-to-day lifestyle and healthcare. We are looking forward to collaborating and contributing to research and innovation with both government and private partners in the genomics application field.

Mission

For 19 years, we have been a team with experience in genetics, genomics, molecular biology, and bioinformatics, sharing an equal enthusiasm to bring change to humanity. We are passionate about delivering the best services in our industry, not only involving consultation, training, and support but also delivering great value to our esteemed customers.

ABOUT US

Who we are

Taking Care of Your Tomorrow

Background

We are fascinated by the revolution of genomics with the addition of new and improved DNA sequencing technologies and its capability to bring change in our day-to-day lifestyle and healthcare. We are looking forward to collaborating and contributing to research and innovation with both government and private partners in the genomics application field.

Mission

For 19 years, we have been a team with experience in genetics, genomics, molecular biology, and bioinformatics, sharing an equal enthusiasm to bring change to humanity. We are passionate about delivering the best services in our industry, not only involving consultation, training, and support but also delivering great value to our esteemed customers.

SERVICES

Empowering healthcare with NGS and AI

We offer advanced Diagnostic Services using Next-Generation Sequencing (NGS) and AI for precise genetic analysis and personalized oncology treatments. Our Research Services drive innovation in oncology through NGS and AI, enhancing diagnostic tools and therapeutic strategies.

Personalized Healthcare

Personalized healthcare at T-CAG LifeSciences is centered on tailoring medical treatment to individual patients based on their unique genetic profiles.

Genetic Disease Predisposition

Our genetic disease predisposition services focus on identifying individuals' susceptibility to various hereditary conditions.

Community Health Support

Community health support at T-CAG LifeSciences aims to improve public health outcomes through comprehensive genomic screening programs.

AI-Based Genome Healthcare

At T-CAG LifeSciences, we are pioneering AI-based genome healthcare research to revolutionize the way genetic data is analyzed and interpreted.

Metagenomics and Healthcare

Our metagenomics research focuses on studying the collective genomes of microbial communities within the human body and their impact on health and disease.

Extramural Research Project

Our extramural research projects involve collaborating with external academic institutions, research organizations, and industry partners to advance genomic science.

SERVICES

Empowering healthcare with NGS and AI

We offer advanced Diagnostic Services using Next-Generation Sequencing (NGS) and AI for precise genetic analysis and personalized oncology treatments. Our Research Services drive innovation in oncology through NGS and AI, enhancing diagnostic tools and therapeutic strategies.

Personalized Healthcare

Personalized healthcare at T-CAG LifeSciencesis centered on tailoring medical treatment to individual patients based on their unique genetic profiles.

Genetic Disease Predisposition

Our genetic disease predisposition services focus on identifying individuals' susceptibility to various hereditary conditions.

Community Health Support

Community health support at T-CAG LifeSciencesaims to improve public health outcomes through comprehensive genomic screening programs.

AI-Based Genome Healthcare

At T-CAG LifeSciences, we are pioneering AI-based genome healthcare research to revolutionize the way genetic data is analyzed and interpreted.

Metagenomics and Healthcare

Our metagenomics research focuses on studying the collective genomes of microbial communities within the human body and their impact on health and disease.

Extramural Research Project

Our extramural research projects involve collaborating with external academic institutions, research organizations, and industry partners to advance genomic science.

FAQ

Frequently Asked Questions

For any other questions, please feel free to contact us.

We specialize in Next-Generation Sequencing (NGS)-based molecular diagnostics, focusing on identifying genetic mutations and abnormalities with advanced AI integration. Our services enable early detection and personalized treatment plans, particularly in oncology.

Our personalized healthcare utilizes NGS and AI technologies to tailor medical treatments based on individual genetic profiles. This approach enhances therapy effectiveness, minimizes adverse effects, and ensures tailored care aligned with each patient's genetic makeup.

We offer genetic disease predisposition analysis using NGS to predict susceptibility to hereditary conditions along with pharmacogenomics for recommendation of patient-centred drugs. This service supports proactive healthcare measures and informed decision-making for patients and healthcare providers.

We envision to integrate AI into NGS to conduct population-wide genetic screening aimed at improving public health outcomes. Our initiatives will help identify prevalent health risks and design targeted community health programs for disease prevention and management.

We leverage over a decade of experience in NGS and AI to pioneer advancements in cancer research. Our focus includes uncovering novel biomarkers and genetic insights, collaborating with leading institutions to develop more effective diagnostic tools and therapeutic strategies.

TESTIMONIALS

What our users say

Here's what our clients around the internet are saying about us.

Amit

@DrAmit

T-CAG LifeSciences will be a trailblazer in integrating Next-Generation Sequencing and AI into healthcare. Their expertise and commitment to innovation will be evident in the precision and reliability of their diagnostic services. As a healthcare provider, I will trust their data and solutions to enhance patient outcomes and support informed decision-making.

Mohit

@DrMohit

T-CAG LifeSciences will be transformative. Their advanced AI-based genome healthcare research will provide us with invaluable insights into genetic patterns, driving innovation in our personalized medicine approaches. Their dedication to excellence and cutting-edge technology will be truly commendable.

TESTIMONIALS

What our users say

Here's what our clients around the internet are saying about us.

Amit

@DrAmit

T-CAG LifeSciences will be a trailblazer in integrating Next-Generation Sequencing and AI into healthcare. Their expertise and commitment to innovation will be evident in the precision and reliability of their diagnostic services. As a healthcare provider, I will trust their data and solutions to enhance patient outcomes and support informed decision-making.

Mohit

@DrMohit

T-CAG LifeSciences will be transformative. Their advanced AI-based genome healthcare research will provide us with invaluable insights into genetic patterns, driving innovation in our personalized medicine approaches. Their dedication to excellence and cutting-edge technology will be truly commendable.

GALLERY

A glimpse into our company

GALLERY

A glimpse into our company

CONTACT

Get in touch with us

Send us a message

Fill the form to contact us

Message

CONTACT

Get in touch with us

Send us a message

Fill the form to contact us

Message

T-CAG LifeSciences

RZB-210A (Third Floor), Nihal Vihar, Delhi-110041

Email: info@tcaglifesciences.com

Phone: +91-80913 66601